{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:42:36Z","timestamp":1772134956617,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gift fund from family in Portland, OR, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41433-023-02706-6","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T12:02:26Z","timestamp":1692446546000},"page":"386-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of autoimmune eye disease in association with Down\u2019s syndrome"],"prefix":"10.1038","volume":"38","author":[{"given":"Amr M.","family":"Zaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirichai","family":"Pasadhika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry C.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryn M.","family":"Burkholder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-685X","authenticated-orcid":false,"given":"Lyndell L.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Llop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazyna","family":"Adamus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"2706_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12098-013-1249-7","volume":"81","author":"N Agarwal Gupta","year":"2014","unstructured":"Agarwal Gupta N, Kabra M. Diagnosis and management of Down syndrome. Indian J Pediatr. 2014;81:560\u20137.","journal-title":"Indian J Pediatr"},{"key":"2706_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome. Lancet. 2000;355:165\u20139.","journal-title":"Lancet"},{"key":"2706_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/adc.2003.046219","volume":"89","author":"MJ Goldacre","year":"2004","unstructured":"Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancers and immune related diseases associated with Down\u2019s syndrome: a record linkage study. Arch Dis Child. 2004;89:1014\u20137.","journal-title":"Arch Dis Child"},{"key":"2706_CR4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/adc.77.2.183g","volume":"77","author":"JC Van Goor","year":"1997","unstructured":"Van Goor JC, Massa GG, Hirasing R. Increased incidence and prevalence of diabetes mellitus in Down\u2019s syndrome. Arch Dis Child. 1997;77:186.","journal-title":"Arch Dis Child"},{"key":"2706_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00125-006-0231-6","volume":"49","author":"R Bergholdt","year":"2006","unstructured":"Bergholdt R, Eising S, Nerup J, Pociot F. Increased prevalence of Down\u2019s syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study. Diabetologia. 2006;49:1179\u201382.","journal-title":"Diabetologia"},{"key":"2706_CR6","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1210\/jc.2002-020855","volume":"87","author":"M Bonamico","year":"2002","unstructured":"Bonamico M, Pasquino AM, Mariani P, Danesi HM, Culasso F, Mazzanti L, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 2002;87:5495\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2706_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/gut.40.4.492","volume":"40","author":"L Gale","year":"1997","unstructured":"Gale L, Wimalaratna H, Brotodiharjo A, Duggan JM. Down\u2019s syndrome is strongly associated with coeliac disease. Gut. 1997;40:492\u20136.","journal-title":"Gut"},{"key":"2706_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2012.12.087","volume":"163","author":"K M\u00e5rild","year":"2013","unstructured":"M\u00e5rild K, Stephansson O, Grahnquist L, Cnattingius S, S\u00f6derman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013;163:237\u201342.","journal-title":"J Pediatr"},{"key":"2706_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4274\/Jcrpe.884","volume":"5","author":"AN Cebeci","year":"2013","unstructured":"Cebeci AN, Guven A, Yildiz M. Profile of hypothyroidism in Down\u2019s syndrome. J Clin Res Pediatr Endocrinol. 2013;5:116\u201320.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2706_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.2012.04610.x","volume":"169","author":"FP Pellegrini","year":"2012","unstructured":"Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, et al. Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol. 2012;169:238\u201343.","journal-title":"Clin Exp Immunol"},{"key":"2706_CR11","doi-asserted-by":"publisher","first-page":"e000890","DOI":"10.1136\/rmdopen-2018-000890","volume":"5","author":"CM Foley","year":"2019","unstructured":"Foley CM, Deely DA, MacDermott EJ, Killeen OG. Arthropathy of Down syndrome: an under-diagnosed inflammatory joint disease that warrants a name change. RMD Open. 2019;5:e000890.","journal-title":"RMD Open"},{"key":"2706_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/archdischild-2018-315751","volume":"104","author":"C Foley","year":"2019","unstructured":"Foley C, Killeen OG. Musculoskeletal anomalies in children with Down syndrome: an observational study. Arch Dis Child. 2019;104:482\u20137.","journal-title":"Arch Dis Child"},{"key":"2706_CR13","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1210\/jc.2005-2611","volume":"91","author":"J Perheentupa","year":"2006","unstructured":"Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91:2843\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"2706_CR14","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.4049\/jimmunol.1400223","volume":"193","author":"M Gim\u00e9nez-Barcons","year":"2014","unstructured":"Gim\u00e9nez-Barcons M, Caster\u00e0s A, Armengol Mdel P, Porta E, Correa PA, Mar\u00edn A, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. J Immunol. 2014;193:3872\u20139.","journal-title":"J Immunol"},{"key":"2706_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","volume":"615","author":"L Malle","year":"2023","unstructured":"Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, Philippot Q, Buta S, et al. Autoimmunity in Down\u2019s syndrome via cytokines, CD4 T cells and CD11c(+) B cells. Nature. 2023;615:305\u201314.","journal-title":"Nature"},{"key":"2706_CR16","doi-asserted-by":"publisher","first-page":"e0216320","DOI":"10.1371\/journal.pone.0216320","volume":"14","author":"K Pl\u00f6ssl","year":"2019","unstructured":"Pl\u00f6ssl K, Straub K, Schmid V, Strunz F, Wild J, Merkl R, et al. Identification of the retinoschisin-binding site on the retinal Na\/K-ATPase. PLoS One. 2019;14:e0216320.","journal-title":"PLoS One"},{"key":"2706_CR17","first-page":"9726261","volume":"2020","author":"A Ugurlu","year":"2020","unstructured":"Ugurlu A, Altinkurt E. Ophthalmologic manifestations and retinal findings in children with Down syndrome. J Ophthalmol. 2020;2020:9726261.","journal-title":"J Ophthalmol"},{"key":"2706_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/bjophthalmol-2012-302327","volume":"97","author":"AH Fong","year":"2013","unstructured":"Fong AH, Shum J, Ng AL, Li KK, McGhee S, Wong D. Prevalence of ocular abnormalities in adults with Down syndrome in Hong Kong. Br J Ophthalmol. 2013;97:423\u20138.","journal-title":"Br J Ophthalmol."},{"key":"2706_CR19","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.ophtha.2003.12.051","volume":"111","author":"J van Splunder","year":"2004","unstructured":"van Splunder J, Stilma JS, Bernsen RM, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology. 2004;111:1457\u201363.","journal-title":"Ophthalmology"},{"key":"2706_CR20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/02713683.2019.1597128","volume":"44","author":"S Mangalesh","year":"2019","unstructured":"Mangalesh S, Vinekar A, Jayadev C, Kemmanu V, Bhat M, Sivakumar M, et al. Spectral domain optical coherence tomography in detecting sub-clinical retinal findings in Asian Indian children with Down syndrome. Curr Eye Res. 2019;44:901\u20137.","journal-title":"Curr Eye Res"},{"key":"2706_CR21","doi-asserted-by":"publisher","first-page":"108317","DOI":"10.1016\/j.clim.2019.108317","volume":"210","author":"G Adamus","year":"2020","unstructured":"Adamus G, Champaigne R, Yang S. Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy. Clin. Immunol. 2020;210:108317.","journal-title":"Clin. Immunol."},{"key":"2706_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17469899.2020.1739522","volume":"15","author":"G Adamus","year":"2020","unstructured":"Adamus G. Current techniques to accurately measure anti-retinal autoantibodies. Expert Rev Ophthalmol. 2020;15:111\u20138.","journal-title":"Expert Rev Ophthalmol"},{"key":"2706_CR23","unstructured":"Sen ES, Ramanan AV, Rosenbaum JT. Uveitis in Juvenile Idiopathic Arthritis. Ch. 22. In: Petty RE, et al. editors. Textbook of pediatric rheumatology. Philadelphia, PA: Elsevier; 2021. p. 279\u201393."},{"key":"2706_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/PHMT.S282646","volume":"13","author":"JT Jones","year":"2022","unstructured":"Jones JT, Kitchen J, Talib N. Down syndrome-associated arthritis (DA): diagnostic and management challenges. Pediatric Health Med Ther. 2022;13:53\u201362.","journal-title":"Pediatric Health Med Ther"},{"key":"2706_CR25","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297.","journal-title":"PLoS Med"},{"key":"2706_CR26","doi-asserted-by":"publisher","first-page":"154938","DOI":"10.1016\/j.cyto.2019.154938","volume":"127","author":"D Huggard","year":"2020","unstructured":"Huggard D, Kelly L, Ryan E, McGrane F, Lagan N, Roche E, et al. Increased systemic inflammation in children with Down syndrome. Cytokine. 2020;127:154938.","journal-title":"Cytokine"},{"key":"2706_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0002-9394(14)70532-X","volume":"121","author":"CA McCannel","year":"1996","unstructured":"McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol. 1996;121:35\u201346.","journal-title":"Am J Ophthalmol."},{"key":"2706_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fped.2020.00073","volume":"8","author":"D Huggard","year":"2020","unstructured":"Huggard D, Doherty DG, Molloy EJ. Immune dysregulation in children with Down syndrome. Front Pediatr. 2020;8:73.","journal-title":"Front Pediatr"},{"key":"2706_CR29","doi-asserted-by":"publisher","first-page":"84489","DOI":"10.18632\/oncotarget.21060","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Che M, Yuan J, Yu Y, Cao C, Qin XY, et al. Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis. Oncotarget. 2017;8:84489\u201396.","journal-title":"Oncotarget"},{"key":"2706_CR30","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1084\/jem.20061864","volume":"203","author":"J DeVoss","year":"2006","unstructured":"DeVoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med. 2006;203:2727\u201335.","journal-title":"J Exp Med"},{"key":"2706_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G de Graaf","year":"2017","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Med. 2017;19:439\u201347.","journal-title":"Genet Med"},{"key":"2706_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491\u2013500.","journal-title":"Ophthalmology"},{"key":"2706_CR33","doi-asserted-by":"publisher","first-page":"102266","DOI":"10.1016\/j.coi.2022.102266","volume":"80","author":"FW Miller","year":"2023","unstructured":"Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266.","journal-title":"Curr Opin Immunol."},{"key":"2706_CR34","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(23)00621-9","volume":"401","author":"X Wen","year":"2023","unstructured":"Wen X, Li B. A population-based study on autoimmune disease. Lancet. 2023;401:1829\u201331.","journal-title":"Lancet"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02706-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T13:06:06Z","timestamp":1706187966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02706-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2706"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02706-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2766021\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"1 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AST: consultant for Alimera, Allergan, Avesis, Bausch & Lomb, Eyepoint, Genentech, Zeiss. SML: Eyepoint Pharmaceuticals. JTR: consultant for Abbvie, Gilead, Roche, Horizon, Eyevensys, Santen, UCB, Corvus, and Affibody; royalties from UpToDate; clinical trial support from Pfizer and Horizon; and data monitoring for BMS-Celgene and Lilly. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}